Tipsheet
What matters at India’s listed companies
Brief /Earnings / Engineering

Rolex Rings settles ₹101 cr liability, approves ₹180 cr buyback as tariffs normalize

Q4 FY26 transcript reveals US order recovery from Q1, 50% domestic growth, and margin expansion to 51.5%.


Mkt cap₹3,906 cr
P/E27.69×
ROE16.23%
Debt / eq.0.01
₹180 cr Buyback approval

What's new with Rolex Rings Ltd

  • US tariffs at 25% normalized; order flows recovering from Q1 FY27.
  • Full settlement of ₹101 crore Right of Recompense obligation.
  • ₹180 crore buyback approved; Europe up 25%, domestic up 50%.

Why this matters for Rolex Rings Ltd

The settlement removes a long-standing balance-sheet overhang, and the buyback signals cash strength and management confidence. With mid-teen revenue guidance for FY27 and gross margins at 51.5%, the company is executing on geographic diversification and margins simultaneously.

What we're watching

  • Whether US order recovery sustains through FY27 under the 25% tariff regime.
  • Further margin expansion potential as domestic revenue doubles.
  • Cadence of buyback execution and impact on equity.

The full read

Rolex Rings has turned a corner. The Q4 FY26 conference call transcript shows a company emerging from tariff uncertainty with a clean balance sheet and a capital return plan. US tariffs have normalized at 25%, and order flows are already recovering from Q1 FY27. Meanwhile, Europe grew 25% and domestic revenue surged 50%, pushing gross margins to 51.5%. The Rs 101 crore Right of Recompense obligation is fully settled, removing a long-standing liability. And the board has approved a Rs 180 crore buyback, a clear vote of confidence. Management guided for mid-teen revenue growth in FY27. The transcript is thick with execution detail — but the core story is simple: Rolex is leaving its overhangs behind and betting on itself.

Mentioned: ₹101 crore Right of Recompense · ₹180 crore buyback · US tariffs 25%
Primary source BSE · NSE · Tijori

Our reading of the company's own disclosure. Always confirm against the original source.